Versantis' Series A Round

Versantis raised a round of funding on March 29, 2017.

Versantis is a pharmaceutical company that focuses on the development of products for the diagnosis, prevention, and treatment of liver diseases. Its lead candidate, VS-01, targets hepatic encephalopa…

Articles about Versantis' Series A Round: